 National clinical standards and cost-effectiveness. CHERE Working Paper 2012/03Working Papers from CHERE, University of Technology, Sydney Abstract: NSW Treasury commissioned this review through the Sax Institute. The aims and specific questions to be addressed were refined after consideration of a background paper, and discussion between NSW Health, NSW Treasury and the author. The aim of the review is to provide information about the ways in which costs and cost effectiveness are being incorporated in the approaches used by agencies within Australia, North America and Europe involved in CPG development and setting standards; and to provide recommendations for the development of the approach to be developed by the ACSQHC. The specific questions this report addresses are: (i) Which countries/health systems have developed and implemented a systematic approach to developing clinical guidelines and/or indicators which include consideration of costs and benefits? (ii) What approaches have been used in Australia? (iii) What evidence is there about the effectiveness or value of these approaches? (iv) What is known about best practice for developing clinical guidelines and/or indicators which include consideration of costs and benefits? (v) What other aspects or issues should be considered in the development of guidelines, standards and indicators? Keywords: clinical standards; cost-effectiveness (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:her:chewps:2012/03 Access Statistics for this paper More papers in Working Papers from CHERE, University of Technology, Sydney Contact information at EDIRC. |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.